Aller au contenu
Nutrition et métabolismeArticle de recherche3 min read

A blood marker mixing CRP, triglycerides and glucose is linked to coronary heart disease

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the National Health and Nutrition Examination Survey 1999-2018. · Frontiers in cardiovascular medicine · 2024 · Article original ↗

À retenir

Among 19,451 US adults, each standard deviation rise in the C-reactive protein-triglyceride glucose index (CTI) was linked to 1.357 times the risk of existing coronary heart disease (CHD). CHD was self-reported by questionnaire at one time point, so the index cannot show future prediction.

Study design

Article de recherche

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Coronary heart disease is a leading cause of death, and better ways to flag who already has it could help screening. The authors tested whether CTI, which combines inflammation (C-reactive protein) with insulin resistance markers (triglycerides and glucose), is associated with CHD and whether it improves detection beyond the Framingham risk score.

Population et méthode

Cross-sectional analysis of 19,451 participants in the US National Health and Nutrition Examination Survey (NHANES) 1999-2010. CHD was ascertained from a questionnaire. Associations with CTI were adjusted for conventional cardiovascular risk factors, examined per SD increase and by quartile, with smooth curve fitting, subgroup analyses and ROC and reclassification analyses on top of the Framingham risk score.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    CHD prevalence was 6.23%.
  2. 2
    After adjustment for conventional risk factors, each SD increase in CTI was associated with 1.357 times the risk of CHD, and the top quartile with 1.807 times the risk of the bottom quartile.
  3. 3
    The association looked linear across the whole CTI range and was robust in several subgroups, but stronger in people aged <60.
  4. 4
    Adding CTI to the Framingham risk score significantly improved identification of CHD in ROC and reclassification analyses.

Limites et incertitude

  1. 1
    Cross-sectional data cannot show whether high CTI precedes CHD or follows it; the multipliers describe association with existing disease.
  2. 2
    CHD was identified by questionnaire, so it relies on self-report and may be misclassified.
  3. 3
    The abstract does not give the size of the improvement from adding CTI, nor whether it holds in an independent sample.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

The index is a research marker, not a test you can use at home, and it relies on blood tests ordered by a clinician. The finding supports the idea that inflammation and insulin resistance travel together with heart disease, but does not say what to do about a given number. Heart risk decisions belong with your clinician.

Vos données

CTI needs lab values for CRP, triglycerides and fasting glucose, none of which a wearable measures. If you receive blood panels, compare results from the same lab and fasting conditions across visits, and treat trends in weight, activity and resting heart rate as separate, general context.

Comprendre ce type de preuve

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Coronary heart disease (CHD) is one of the leading causes of mortality. The current study aims to assess the association between C-reactive protein-triglyceride glucose index (CTI) and the risk of prevalent CHD and to evaluate the usefulness of CTI to refine the identification of prevalent CHD.

Methods

19,451 subjects from the National Health and Nutrition Examination Survey 1999-2010 were enrolled. CHD was ascertained according to the questionnaire.

Results

The prevalent of CHD was 6.23%. After adjusting for conventional cardiovascular risk factors, each SD increase of CTI could cast a 1.357 times risk of CHD. In quartile analysis, the top quartile had a 1.807 times risk of CHD than the bottom quartile. Smooth curving fitting displayed that the association was linear in the entire range of CTI. Subgroup analysis revealed that the association was robust among several common subpopulations but stronger in subjects aged <60. Finally, both ROC and reclassification analysis demonstrated a significant improvement in identifying CHD when introducing CTI to the Framingham risk score.

Conclusion

CTI has a positive, linear, and robust association with prevalent CHD in the general American population, and CTI may help to improve the detection of prevalent CHD in the general population.

Sources et attribution

Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the National Health and Nutrition Examination Survey 1999-2018.

Xu M, Zhang L, Xu D, Shi W, Zhang W.

Frontiers in cardiovascular medicine · 2024-10-15

DOI: 10.3389/fcvm.2024.1485538 ↗PubMed · 39473894 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse d’essais

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

Explications approfondiesLire l’étude →
·Essai randomisé

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Nutrition et métabolisme →